Bosch FX, Lorincz A, Munõz N et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265.
Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002;3:11-16.
Crum CP, Ikenberg H, Richart RM et al. Human papillomavirus type 16 and early cervical neoplasia. N Engl J Med 1984;310:880-883.
Marsh M. Original site of cervical carcinoma; topographical relationship of carcinoma of the cervix to the external os and to the squamocolumnar junction. Obstet Gynecol 1956;7:444-452.
Wang X, Ouyang H, Yamamoto Y et al. Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 2011;145:1023-1035.
Herfs M, Yamamoto Y, Laury A et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci USA 2012;109:10516-10521.
Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 2010;46:S20-S26.
Frisch M, Glimelius B, van den Brule AJ et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997;337:1350-1358.
Tilston P. Anal human papillomavirus and anal cancer. J Clin Pathol 1997;50:625-634.
Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000;342:792-800.
Clark MA, Hartley A, Geh JI. Cancer of the anal canal. Lancet Oncol 2004;5:149-157.
Parkin DM. The global health burden of infectionassociated cancers in the year 2002. Int J Cancer 2006; 118:3030-3044.
Forman D, de Martel C, Lacey CJ et al. Global burden of human papillomavirus and related diseases. Vaccine 2012;30:F12-F23.
Palefsky JM, Holly EA, Ralston ML et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and highrisk HIV-negative women. J Infect Dis 2001;183:383-391.
Williams AB, Darragh TM, Vranizan K et al. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:205-211.
Hernandez BY, McDuffie K, Zhu X et al. Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomark Prev 2005;14:2550-2556.
Fenger C. The anal transitional zone. A method for macroscopic demonstration. Acta Pathol Microbiol Scand [A] 1978;86:225-230.
Herfs M, Vargas SO, Yamamoto Y et al. A novel blueprint for "top down" differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J Pathol 2013;229:460-468.
Xian W, Ho KY, Crum CP et al. Cellular origin of Barrett's esophagus: controversy and therapeutic implications. Gastroenterology 2012;142:1424-1430.
Odze RD. Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol 2005;100:1853-1867.
Williams GR, Talbot IC, Northover JM et al. Keratin expression in the normal anal canal. Histopathology 1995;26:39-44.
Williams GR, Talbot IC, Leigh IM. Keratin expression in anal carcinoma: an immunohistochemical study. Histopathology 1997;30:443-450.
Fritsch H, Zehm S, Illig R et al. New insights into the development and differentiation of the human anorectal epithelia. Are there clinical consequences? Int J Colorectal Dis 2010;25: 1231-1242.
Roberts JN, Buck CB, Thompson CD et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 2007;13:857-861.
Letian T, Tianyu Z. Cellular receptor binding and entry of human papillomavirus. Virol J 2010;7:2.
Huang H-S, Lambert PF. Use of an in vivo animal model for assessing the role of integrin (6) (4) and syndecan-1 in early steps in papillomavirus infection. Virology 2012;433:395-400.